The HIV Vaccine Trials Network (HVTN) is the world’s largest publicly-funded international collaboration focused on the development of vaccines to prevent HIV/AIDS.
Main Areas of Focus
- To fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV infections globally
- HVTN Executive Management Team
- HVTN Science Governance Committee
- DAIDS Vaccine Research Program and Vaccine Clinical Research Branch